drugset / Trial / NCT00606697

A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia

NCT00606697

Phase 2 Completed 51 enrolled GlaxoSmithKline
RandomizedCrossoverTreatment

Summary

Patients with Primary Insomnia will be treated with GW597599 and GR205171 to evaluate the efficacy in the sleep difficulties associated with insomnia

Timeline

Start
2007-12-19
Primary completion
2008-05-07
Completion
2008-05-07

Publications

  • Background This study has not been published in the scientific literature.

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vestipitant Small molecule 15 mg
Comparator Vofopitant Small molecule 10 mg